Cited by 3,627Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Whitehouse, PJ, Price, DL, Struble, RG, Clark, AW, Coyle, JT, DeLong, Mahlon R.·1982·Science

DOI 10.1126/science.7058341

Open this paper in CoChat — free account

Abstract

Recent evidence indicates that the nucleus basalis of Meynert, a distinct population of basal forebrain neurons, is a major source of cholinergic innervation of the cerebral cortex. Postmortem studies have previously demonstrated profound reduction in the presynaptic markers for cholinergic neurons in the cortex of patients with Alzheimer's disease and senile dementia of the Alzheimer's type. The results of this study show that neurons of the nucleus basalis of Meynert undergo a profound (greater than 75 percent) and selective degeneration in these patients and provide a pathological substrate of the cholinergic deficiency in their brains. Demonstration of selective degeneration of such neurons represents the first documentation of a loss of a transmitter-specific neuronal population in a major disorder of higher cortical function and, as such, points to a critical subcortical lesion in Alzheimer's patients.

Integrity signals

Registry

Crossref · 10.1126/science.7058341

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Self-citation
APRIORITY
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,293
Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat
Krettek, J. E., & Price, J. L. (1978) · Journal of Comparative Neurology · doi:10.1002/cne.901780204 · Cited by 1,293
The connections of the septal region in the rat
Swanson, L. W., & Cowan, W. M. (1979) · The Journal of Comparative Neurology · doi:10.1002/cne.901860408 · Cited by 1,136
THE ASCENDING CHOLINERGIC RETICULAR SYSTEM: NEOCORTICAL, OLFACTORY AND SUBCORTICAL PROJECTIONS
Shute, C. C. D., & Lewis, P. R. (1967) · Brain · doi:10.1093/brain/90.3.497 · Cited by 1,120
HIPPOCAMPAL PROJECTIONS AND RELATED NEURAL PATHWAYS TO THE MID-BRAIN IN THE CAT
Nauta, W. J. H. (1958) · Brain · doi:10.1093/brain/81.3.319 · Cited by 990
Some morphometric aspects of the brain in senile dementia of the alzheimer type
Terry, R. D., Peck, A., DeTeresa, R., Schechter, R., & Horoupian, D. S. (1981) · Annals of Neurology · doi:10.1002/ana.410100209 · Cited by 801
Activity of pallidal neurons during movement.
DeLong, M. R. (1971) · Journal of Neurophysiology · doi:10.1152/jn.1971.34.3.414 · Cited by 734
Self-citation
Neurotransmitter enzyme abnormalities in senile dementia
Perry, E. K., Gibson, P. H., Blessed, G., Perry, R. H., & Tomlinson, B. E. (1977) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(77)90073-9 · Cited by 724

Flagged first, then by citations

Show all 44 references

Research works printed but not linked: 10

Brody, H., Alzheimer's Disease: Senile Dementia and Related Disorders 7: 345 (1978).
Coyle, J. T., Brain Neurotransmitters and Receptors in Aging and Age-Related Disorders: 149 (1981).
DAVIS, K.L., BRAIN ACETYLCHOLINE: 205 (1979).
DRACHMAN, D.A., AGING 7: 141 (1978).
HASSLER, R, BEHAV AGING NERVOUS: 284 (1965).
KUHAR, M.J., BIOL CHOLINERGIC FUN: 3 (1976).
PARENT, A, ADVANCES IN NEUROLOGY 24: 1 (1979).
TOMLINSON, B.E., DEMENTIA: 113 (1977).
WANG, H, AGING DEMENTIA: 1 (1977).
WANG, H.S., REPORT PANEL INFLAMM: 61 (1979).

Sorted by citations

Items 201–300 of 1,021

Entorhinal cortex dysfunction in Alzheimer's disease
Igarashi, K. M. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.11.006 · Cited by 276
The role of cortical connectivity in Alzheimer's disease pathogenesis: A review and model system
LACOSTE, M. C. D., & White, C. L. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90015-4 · Cited by 254
Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia
Goodenowe, D. B., Cook, L. L., Liu, J., Lu, Y., Jayasinghe, D., Ahiahonu, P. W. K., Heath, D., Yamazaki, Y., Flax, J., Krenitsky, K. F., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.p700023-jlr200 · Cited by 259
Individual differences in aging: Behavioral and neurobiological correlates
Markowska, A. L., Stone, W. S., Ingram, D. K., Reynolds, J., Gold, P. E., Conti, L. H., Pontecorvo, M. J., Wenk, G. L., & Olton, D. S. (1989) · Neurobiology of Aging · doi:10.1016/s0197-4580(89)80008-9 · Cited by 256
Convenient and Continuous Fluorometric Assay Method for Acetylcholinesterase and Inhibitor Screening Based on the Aggregation-Induced Emission
Wang, M., Gu, X., Zhang, G., Zhang, D., & Zhu, D. (2009) · Analytical Chemistry · doi:10.1021/ac9002722 · Cited by 251
Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and down's syndrome
Yates, C. M., Simpson, J. A., Gordon, A., Maloney, A. F. J., Allison, Y., Ritchie, I. M., & Urquhart, A. L. (1983) · Brain Research · doi:10.1016/0006-8993(83)91179-4 · Cited by 251
Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease.
Michalski, B., & Fahnestock, M. (2003) · Brain Research. Molecular Brain Research · doi:10.1016/s0169-328x(03)00003-2 · Cited by 269
Intermittent Fasting Alleviates the Increase of Lipoprotein Lipase Expression in Brain of a Mouse Model of Alzheimer's Disease: Possibly Mediated by β-hydroxybutyrate
Zhang, J., Li, X., Ren, Y., Zhao, Y., Xing, A., Jiang, C., Chen, Y., & An, L. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00001 · Cited by 255
Novel Functions of Cholinesterases in Development, Physiology and Disease
Layer, P. G., & Willbold, E. (1994) · Progress in Histochemistry and Cytochemistry · doi:10.1016/s0079-6336(11)80046-x · Cited by 249
Cholinergic Innervation in Neuritic Plaques
Struble, R. G., Cork, L. C., Whitehouse, P. J., & Price, D. L. (1982) · Science · doi:10.1126/science.6803359 · Cited by 249
Self-citation
The neurobiologie consequences of down syndrome
Coyle, J. T., Oster-Granite, M. L., & Gearhart, J. D. (1986) · Brain Research Bulletin · doi:10.1016/0361-9230(86)90074-2 · Cited by 248
Self-citation
Aminergic systems in Alzheimer's disease and Parkinson's disease
D’Amato, R. J., Zweig, R. M., Whitehouse, P. J., Wenk, G. L., Singer, H. S., Mayeux, R. P., Price, D. L., & Snyder, S. H. (1987) · Annals of Neurology · doi:10.1002/ana.410220207 · Cited by 248
Self-citation
Selective memory loss following nucleus basalis lesions: Long term behavioral recovery despite persistent cholinergic deficiencies
Bartus, R. T., Flicker, C., Dean, R. L., Pontecorvo, M. J., Figueiredo, J. C., & Fisher, S. K. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90139-x · Cited by 246
Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis
Lyness, S. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00057-x · Cited by 240
Decreased level of nerve growth factor (NGF) and its messenger RNA in the aged rat brain
Lärkfors, L., Ebendal, T., Whittemore, S. R., Persson, H., Hoffer, B. J., & Olson, L. (1987) · Molecular Brain Research · doi:10.1016/0169-328x(87)90044-1 · Cited by 245
Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: Colocalization with cholinergic neurons
Mufson, E. J., Bothwell, M. A., Hersh, L. B., & Kordower, J. H. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902850204 · Cited by 245
“Limbic Predilection in Alzheimer Dementia: Is Reactivated Herpesvirus Involved?”
Ball, M. J. (1982) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100044115 · Cited by 243
Evaluation of Estrogen Treatment in Female Patients with Dementia of the Alzheimer Type.
Ohkura, T., Isse, K., Akazawa, K., Hamamoto, M., Yoshimasa, Y. A. O. I., & Hagino, N. (1994) · Endocrine Journal · doi:10.1507/endocrj.41.361 · Cited by 244
Familial Alzheimer Dementia: a prevalent disorder with specific clinical features
Breitner, J. C. S., & Folstein, M. F. (1984) · Psychological Medicine · doi:10.1017/s0033291700003081 · Cited by 244
Regional changes in brain glucose metabolism reflect cognitive impairments in aged rats
Gage, F. H., Kelly, P., & Björklund, A. (1984) · Journal of Neuroscience · doi:10.1523/jneurosci.04-11-02856.1984 · Cited by 246
Zinc takes the center stage: its paradoxical role in Alzheimer’s disease
Cuajungco, M. P., & Faget, K. Y. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00219-9 · Cited by 245
Quantification of brain cholinergic denervation in Alzheimer’s disease using PET imaging with [18F]-FEOBV
Aghourian, M., Legault-Denis, C., Soucy, J.-P., Rosa-Neto, P., Gauthier, S., Kostikov, A., Gravel, P., & Bédard, M.-A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.183 · Cited by 220
Research and Development of Donepezil Hydrochloride, a New Type of Acetylcholinesterase Inhibitor
Sugimoto, H., Ogura, H., Arai, Y., Iimura, Y., & Yamanishi, Y. (2002) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.89.7 · Cited by 240
Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age
Mann, D. M. A., Yates, P. O., & Marcyniuk, B. (1985) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(85)90129-7 · Cited by 240
Oral physostigmine treatment of patients with Alzheimer's disease
Mohs, R. C., Davis, B. J., Johns, C. A., Mathé, A. A., GREENWALD, B. S., Horvath, T., & Davis, K. L. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.1.28 · Cited by 239
Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of meynert in Alzheimer's disease
Perry, R. H., Candy, J., Perry, E. K., et al. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90391-3 · Cited by 240
Differential vulnerability of central neurons of the rat to quinolinic acid
Schwarcz, R., & Köhler, C. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90115-5 · Cited by 239
Transplantation of embryonic ventral forebrain neurons to the neocortex of rats with lesions of nucleus basalis magnocellularis—II. Sensorimotor and learning impairments
Dunnett, S. B., Toniolo, G., Fine, A., Ryan, C. N., Björklund, A., & Iversen, S. D. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90094-6 · Cited by 238
Disruption of central cholinergic systems in the rat by basal forebrain lesions or atropine: Effects on feeding, sensorimotor behaviour, locomotor activity and spatial navigation
Whishaw, I. Q., O'Connor, W. T., & Dunnett, S. B. (1985) · Behavioural Brain Research · doi:10.1016/0166-4328(85)90023-3 · Cited by 237
Increased Synaptic Sprouting in Response to Estrogen via an Apolipoprotein E-Dependent Mechanism: Implications for Alzheimer’s Disease
Stone, D. J., Rozovsky, I., Morgan, T. E., Anderson, C. P., & Finch, C. E. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03180.1998 · Cited by 237
Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
Imahori, K., & Uchida, T. (1997) · PubMed · Cited by 236
Increased proNGF Levels in Subjects with Mild Cognitive Impairment and Mild Alzheimer Disease
Peng, S., Wuu, J., Mufson, E. J., & Fahnestock, M. L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.6.641 · Cited by 236
Therapeutic Opportunities for Muscarinic Receptors in the Central Nervous System
Felder, C. C., Bymaster, F. P., Ward, J. S., & DeLapp, N. W. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990607u · Cited by 235
The LIM-homeobox gene Lhx8 is required for the development of many cholinergic neurons in the mouse forebrain
Zhao, Y., Marín, O., Hermesz, E., Powell, A., Flames, N., Palkovits, M., Rubenstein, J. L. R., & Westphal, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1537759100 · Cited by 227
Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases
Alam, M., Ahmed, S., Elasbali, A. M., Adnan, M., Alam, S., Hassan, M. I., & Pasupuleti, V. R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.860508 · Cited by 234
Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease
Crutcher, K. A., Scott, S. A., Liang, S., Everson, W. V., & Weingartner, J. A. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-06-02540.1993 · Cited by 233
Intact acquisition and long-term retention of mirror-tracing skill in Alzheimer's disease and in global amnesia.
Gabrieli, J. D. E., Corkin, S., Mickel, S. F., & Growdon, J. H. (1993) · Behavioral Neuroscience · doi:10.1037//0735-7044.107.6.899 · Cited by 234
Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer’s disease
de la Monte, S. M. (1989) · Annals of Neurology · doi:10.1002/ana.410250506 · Cited by 229
Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
Wilcock, D. M., & Griffin, W. S. T. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-84 · Cited by 230
Memory dysfunction and word priming in dementia and amnesia.
Shimamura, A. P., Salmon, D. P., Squire, L. R., & Butters, N. (1987) · Behavioral Neuroscience · doi:10.1037//0735-7044.101.3.347 · Cited by 229
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer’s disease
Rafii, M. S., Baumann, T. L., Bakay, R. A. E., Ostrove, J. M., Siffert, J., Fleisher, A. S., Herzog, C. D., Barba, D., Pay, M., Salmon, D. P., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.09.004 · Cited by 223
New approaches to symptomatic treatments for Alzheimer’s disease
Cummings, J. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00424-9 · Cited by 226
Pharmacologic treatments of dementia
Bonner, L. T., & Peskind, E. R. (2002) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00007-x · Cited by 226
Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients
Morrison, J. H., Rogers, J., Scherr, S., Benoit, R., & Bloom, F. E. (1985) · Nature · doi:10.1038/314090a0 · Cited by 264
Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations
DeKosky, S. T., Harbaugh, R. E., Schmitt, F. A., Bakay, R. A. E., Chui, H. C., Knopman, D. S., Reeder, T. M., Shetter, A. G., Senter, H. J., Markesbery, W. R., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410320505 · Cited by 223
Cerebral Blood Flow Correlates of Apathy in Alzheimer Disease
Craig, A., Cummings, J. L., Fairbanks, L. A., Itti, L., Miller, B. L., Li, J. J., & Mena, I. G. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550110056012 · Cited by 223
Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease
Cataldo, A. M., Hamilton, D. J., & Nixon, R. A. (1994) · Brain Research · doi:10.1016/0006-8993(94)91858-9 · Cited by 185
Alzheimer's disease: Choline acetyltransferase activity in brain tissue from clinical and pathological subgroups
Bird, T. D., Stranahan, S. I., Sumi, S. M., & Raskind, M. A. (1983) · Annals of Neurology · doi:10.1002/ana.410140306 · Cited by 222
Dopaminergic and cholinergic lesions in progressive supranuclear palsy
Ruberg, M., Javoy-Agid, F., Hirsch, É. C., Scatton, B., L'Heureux, R., Hauw, J., Duyckaerts, C. J., Gray, F., Morel-Maroger, A., Rascol, A., et al. (1985) · Annals of Neurology · doi:10.1002/ana.410180503 · Cited by 223
Immunocytochemical localization of a neuronal nicotinic receptor: the beta 2-subunit
Hill, J., Zoli, M., Bourgeois, J., & Changeux, J. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01551.1993 · Cited by 220
Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
Sahni, J. K., Doggui, S., Ali, J., Baboota, S., Dao, L., & Ramassamy, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.033 · Cited by 219
Fetal‐Type Phosphorylation of the τ in Paired Helical Filaments
Kanemaru, K., Takio, K., Miura, R., Titani, K., & Ihara, Y. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10039.x · Cited by 197
Adeno-Associated Viral Vector (Serotype 2)–Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial
Rafii, M. S., Tuszynski, M. H., Thomas, R. G., Barba, D., Brewer, J. B., Rissman, R. A., Siffert, J., Aisen, P. S., & for the AAV2-NGF Study Team (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0233 · Cited by 219
Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease?
Correia, S. C., Santos, R. X., Perry, G., Zhu, X., Moreira, P. I., & Smith, M. A. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.01.001 · Cited by 212
Cell number changes in Alzheimer's disease relate to dementia, not to plaques and tangles
Andrade-Moraes, C. H., de Oliveira-Pinto, A. V., Castro-Fonseca, E., da Silva, C. G., Guimarães, D. M., Szczupak, D., Parente-Bruno, D. R., Carvalho, L. R. B., Polichiso, L., Valério‐Gomes, B., et al. (2013) · Brain · doi:10.1093/brain/awt273 · Cited by 223
Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease
Mufson, E. J., Ma, S. Y., Cochran, E. J., Bennett, D. A., Beckett, L., Jaffar, S., Saragovi, H. U., & Kordower, J. H. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001106)427:1 · Cited by 219
In Vivo Fatty Acid Incorporation into Brain Phosholipids in Relation to Plasma Availability, Signal Transduction and Membrane Remodeling
Rapoport, S. I. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:16:2-3:243 · Cited by 215
Estrogen binding and estrogen receptor characterization (ERα and ERβ) in the cholinergic neurons of the rat basal forebrain
Shughrue, P. J., Scrimo, P. J., & Merchenthaler, I. J. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00520-5 · Cited by 215
Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: Forebrain
Cortés, R., Probst, A., & Palacios, J. M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90006-6 · Cited by 215
Role of Neuroimaging in Alzheimer's Disease, with Emphasis on Brain Perfusion SPECT
Matsuda, H. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037218 · Cited by 211
EXCITATORY AMINOACID ANTAGONISTS PROVIDE A THERAPEUTIC APPROACH TO NEUROLOGICAL DISORDERS
Schwarcz, R. M. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90238-7 · Cited by 214
Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease
Etienne, P. E., Robitaille, Y., Wood, P. L., Gauthier, S. G., Nair, N. P. V., & Quirion, R. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90142-9 · Cited by 213
The Cholinergic Hypothesis of Memory: A Review of Animal Experiments
Hagan, J. J., & Morris, R. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8_7 · Cited by 212
The cholinergic hypothesis of cognitive aging revisited again: Cholinergic functional compensation
Dumas, J. A., & NEWHOUSE, P. A. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.022 · Cited by 223
Alzheimer's centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects
Hodges, J. R. (2006) · Brain · doi:10.1093/brain/awl275 · Cited by 227
Estrogen and Basal Forebrain Cholinergic Neurons: Implications for Brain Aging and Alzheimer's Disease-Related Cognitive Decline
Gibbs, R. B., & Aggarwal, P. (1998) · Hormones and Behavior · doi:10.1006/hbeh.1998.1451 · Cited by 212
The anatomy of the CNS cholinergic neurons
Cuello, A. C., & Sofroniew, M. V. (1984) · Trends in Neurosciences · doi:10.1016/s0166-2236(84)80161-7 · Cited by 212
Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease
Behl, C. (1997) · Cell and Tissue Research · doi:10.1007/s004410050955 · Cited by 212
AF64A, a cholinergic neurotoxin, selectively depletes acetylcholine in hippocampus and cortex, and produces long-term passive avoidance and radial-arm maze deficits in the rat
Walsh, T. J., Tilson, H. A., DeHaven, D. L., Mailman, R. B., Fisher, A., & Hanin, I. (1984) · Brain Research · doi:10.1016/0006-8993(84)90684-x · Cited by 211
Anesthesiology and cognitive impairment: a narrative review of current clinical literature
Belrose, J. C., & Noppens, R. R. (2019) · BMC Anesthesiology · doi:10.1186/s12871-019-0903-7 · Cited by 211
The role of cholinergic projections from the nucleus basalis in memory
Dekker, A. D. J. A. M., Connor, D. J., & Thal, L. J. (1991) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80008-9 · Cited by 211
Berberine and neurodegeneration: A review of literature
Ahmed, T., Gilani, A. H., Abdollahi, M. R., Daglia, M., Nabavi, S. F., & Nabavi, S. M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.03.002 · Cited by 212
Nicotinic Acetylcholine Receptor-Mediated Neuroprotection by Donepezil Against Glutamate Neurotoxicity in Rat Cortical Neurons
Takada, Y., Yonezawa, A., Kume, T., Katsuki, H., Kaneko, S., Sugimoto, H., & Akaike, A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.050104 · Cited by 209
Developmental change in the nerve growth factor action from induction of choline acetyltransferase to promotion of cell survival in cultured basal forebrain cholinergic neurons from postnatal rats
Hatanaka, H., Tsukui, H., & Nihonmatsu, I. (1988) · Developmental Brain Research · doi:10.1016/0165-3806(88)90069-7 · Cited by 208
Estrogens and age-related memory decline in rodents: What have we learned and where do we go from here?
Frick, K. M. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2008.08.015 · Cited by 205
Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases
Martin, L. J. (2010) · Pharmaceuticals · doi:10.3390/ph3040839 · Cited by 213
Attentional networks in normal aging and Alzheimer's disease.
Fernandez‐Duque, D., & Black, S. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.2.133 · Cited by 215
β-Amyloid and the Pathogenesis of Alzheimer's Disease
Flier, J. S., Underhill, L. H., Yankner, B. A., & Mesulam, M. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112263252605 · Cited by 208
Estrogen therapy and cognition: a review of the cholinergic hypothesis
Gibbs, R. B. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0036 · Cited by 206
Reduced Numbers of Somatostatin Receptors in the Cerebral Cortex in Alzheimer's Disease
Beal, M. F., Mazurek, M. F., Tran, V. T., Chattha, G., Bird, E. D., & Martin, J. B. (1985) · Science · doi:10.1126/science.2861661 · Cited by 251
Modeling Alzheimer’s disease in transgenic rats
Carmo, S. D., & Cuello, A. C. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-37 · Cited by 214
Effect of Tacrine on Behavioral Symptoms in Alzheimer's Disease: An Open-Label Study
Kaufer, D., Cummings, J. L., & Christine, D. (1996) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879600900101 · Cited by 204
The concept of subcortical and cortical dementia: Another look
Whitehouse, P. J. (1986) · Annals of Neurology · doi:10.1002/ana.410190102 · Cited by 204
Self-citation
A Novel mRNA of the A4 Amyloid Precursor Gene Coding for a Possibly Secreted Protein
de Sauvage, F. J., & Octave, J. (1989) · Science · doi:10.1126/science.2569763 · Cited by 206
GAP-43 and BASP1 in Axon Regeneration: Implications for the Treatment of Neurodegenerative Diseases
Chung, D., Shum, A. K., & Caraveo, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.567537 · Cited by 209
Nucleus basalis stimulation facilitates thalamocortical synaptic transmission in the rat auditory cortex
Metherate, R., & Ashe, J. H. (1993) · Synapse · doi:10.1002/syn.890140206 · Cited by 203
Alzheimer's disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex
German, D. C., White, C. L., & Sparkman, D. R. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90123-0 · Cited by 204
Mechanisms of Neuroprotective Effects of Nicotine and Acetylcholinesterase Inhibitors: Role of α4 and α7 Receptors in Neuroprotection
Akaike, A., Takada‐Takatori, Y., Kume, T., & Izumi, Y. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9236-1 · Cited by 200
GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment
Xu, Y., Zhao, M., Han, Y., & Zhang, H. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00660 · Cited by 203
Cortical cholinergic fibers in aging and Alzheimer's disease: A morphometric study
Geula, C., & Mesulam, M. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90399-0 · Cited by 202
The neuropathology of Alzheimer's disease: A review with pathogenetic, aetiological and therapeutic considerations
Mann, D. M. A. (1985) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(85)90092-2 · Cited by 201
Abnormalities of the nucleus basalis in Down's syndrome
Casanova, M. F., Walker, L. C., Whitehouse, P. J., & Price, D. L. (1985) · Annals of Neurology · doi:10.1002/ana.410180306 · Cited by 202
Self-citation
The nucleus basalis of Meynert in neurological disease: A quantitative morphological study
Rogers, J., BROGAN, D. R., & Mirra, S. S. (1985) · Annals of Neurology · doi:10.1002/ana.410170210 · Cited by 202
Antioxidant and anticholinesterase evaluation of selected Turkish Salvia species
Orhan, İ. E., Kartal, M., Naz, Q., Ejaz, A., Yılmaz, G., Kan, Y., Konuklugil, B., Şener, B., & Choudhary, M. I. (2006) · Food Chemistry · doi:10.1016/j.foodchem.2006.10.030 · Cited by 202
Early neurone loss in Alzheimer’s disease: cortical or subcortical?
Arendt, T., Brückner, M. K., Morawski, M., Jäger, C., & Gertz, H. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0187-1 · Cited by 209
Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease
Farlow, M. R., Lahiri, D. K., Poirier, J., Davignon, J., Schneider, L., & Hui, S. L. (1998) · Neurology · doi:10.1212/wnl.50.3.669 · Cited by 199
The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer’s Disease
Bekdash, R. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031273 · Cited by 222
Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease
Rylett, R. J., Ball, M. J., & Colhoun, E. H. (1983) · Brain Research · doi:10.1016/0006-8993(83)90017-3 · Cited by 198
The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling
Roßner, S. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00044-6 · Cited by 195
Loss of basal forebrain P75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease
Mufson, E. J., Ma, S. Y., Dills, J. L., Cochran, E. J., Leurgans, S. E., Wuu, J., Bennett, D. A., Jaffar, S., Gilmor, M. L., Levey, A. I., et al. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10122 · Cited by 198

Authors: Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R.
Affiliations: Johns Hopkins University (US)
Neuropathology Laboratory, Departments of Pathology and Neurology, Baltimore, Maryland 21205
Departments of Pharmacology and Experimental Therapy, Psychiatry, and Neuroscience, Baltimore, Maryland 21205
ORCID: DeLong, Mahlon R.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1982-03-05
Volume: 215
Issue: 4537
Pages: 1237-1239
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.7058341
OpenAlex: W2093374391
Semantic Scholar: e0380e88fdffd5a546eb76a1d2eb7d05db143f94
Cited by: 3,627
References: 44
Citations by year: 2026: 52 · 2025: 42 · 2024: 53 · 2023: 67 · 2022: 62 · 2021: 91 · 2020: 95 · 2019: 66 · 2018: 63 · 2017: 66 · 2016: 82 · 2015: 65 · 2014: 73 · 2013: 63 · 2012: 56
FWCI: 110.00
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: Alzheimer's disease, senile dementia, nucleus basalis of Meynert, basal forebrain, cholinergic neurons, neuronal loss, cholinergic deficit, cerebral cortex, presynaptic markers, subcortical lesions
MeSH terms: Acetylcholine, Alzheimer Disease, Basal Ganglia, Dementia, Humans, Neural Pathways

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks